News
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
Print Subscription
eNewsletter

logo
Spotlight
OncLive® National Fellows Forum: Lung Cancer 2023
Join us in Chicago for Giants of Cancer Care®
Specialty
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
OncClub
All Oncology News
Pipeline Report
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conference Coverage
Conference Listing
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
OncologyLive
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Interactive Tools
Learning Modules
Presentations
Sponsored
Print Subscription
eNewsletter
Advertisement
Urothelial Cancer
| Breast Cancer
| Lung Cancer
| Gastrointestinal Cancer
| Genitourinary Cancers
| Ovarian Cancer
| Prostate Cancer
| Melanoma & Skin Cancer
| Mantle Cell Lymphoma
| Myeloproliferative Neoplasms
| Biosimilars
| Brain Cancer
| Business Management
| CAR T-cell Therapy
| COVID-19
| Chronic Lymphocytic Leukemia
| Colorectal Cancer
| Disparities in Cancer Care
| Global Oncology
| Gynecologic Oncology
| Head & Neck Cancers
| Hematologic Oncology
| Immuno-Oncology
| Multiple Myeloma
| Neoadjuvant HER2+
| Non-Hodgkin Lymphoma
| Oncology Nursing News
| Pediatric Oncology
| Precision Medicine in Oncology®
| Sarcomas/TGCT
| Supportive Care
View All >>
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
  • Business Management
  • CAR T-cell Therapy
  • COVID-19
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Global Oncology
  • Gynecologic Oncology
  • Head & Neck Cancers
  • Hematologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Mantle Cell Lymphoma
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Neoadjuvant HER2+
  • Non-Hodgkin Lymphoma
  • Oncology Nursing News
  • Ovarian Cancer
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Prostate Cancer
  • Sarcomas/TGCT
  • Supportive Care
  • Urothelial Cancer

SPOTLIGHT -

OncLive® National Fellows Forum: Lung Cancer 2023
| Join us in Chicago for Giants of Cancer Care®

Krish Patel, MD, Swedish Medical Center

home / authors / krish-patel-md-swedish-medical-center

Articles


Next Steps in Mantle Cell Lymphoma

Next Steps in Mantle Cell Lymphoma

March 2nd 2021

Read More


MRD Assessment in Mantle Cell Lymphoma

MRD Assessment in Mantle Cell Lymphoma

March 2nd 2021

Read More


Novel Therapies in the Pipeline in Mantle Cell Lymphoma

Novel Therapies in the Pipeline in Mantle Cell Lymphoma

March 2nd 2021

Read More


MCL: Emerging BTKi-Combination Approaches

MCL: Emerging BTKi-Combination Approaches

February 23rd 2021

Read More


Emerging BTK Inhibitors in Mantle Cell Lymphoma

Emerging BTK Inhibitors in Mantle Cell Lymphoma

February 23rd 2021

Read More


CAR T-Cell Therapy for R/R Mantle Cell Lymphoma

CAR T-Cell Therapy for R/R Mantle Cell Lymphoma

February 16th 2021

Read More


Venetoclax in Mantle Cell Lymphoma

Venetoclax in Mantle Cell Lymphoma

February 16th 2021

Read More


BTK Inhibitors for Relapsed MCL: Important Considerations

BTK Inhibitors for Relapsed MCL: Important Considerations

February 9th 2021

Read More


Selecting a BTKi for Relapsed MCL Treatment

Selecting a BTKi for Relapsed MCL Treatment

February 9th 2021

Read More


Acalabrutinib and Zanubrutinib for Relapsed MCL

Acalabrutinib and Zanubrutinib for Relapsed MCL

February 2nd 2021

Read More


BTK Inhibitors for Relapsed Mantle Cell Lymphoma

BTK Inhibitors for Relapsed Mantle Cell Lymphoma

February 2nd 2021

Read More


Lenalidomide and Bortezomib for Mantle Cell Lymphoma

Lenalidomide and Bortezomib for Mantle Cell Lymphoma

January 26th 2021

Read More


Go-To Treatment Regimens in Mantle Cell Lymphoma

Go-To Treatment Regimens in Mantle Cell Lymphoma

January 26th 2021

Read More


Treatment Approaches in Mantle Cell Lymphoma

Treatment Approaches in Mantle Cell Lymphoma

January 19th 2021

Read More


Accurately Diagnosing Mantle Cell Lymphoma

Accurately Diagnosing Mantle Cell Lymphoma

January 19th 2021

Read More

Latest Conference Coverage

in Genitourinary, Gastrointestinal, and Breast Cancers, Plus Sarcoma and Melanoma at ASCO 2023: Drs Rini, Lewis, Trent, Luke, Kunz, and Lustberg

ZUMA-7 Primary OS Analysis Supports Use of Axi-cel As Second-line SOC in R/R LBCL

Sintilimab Plus Chemoradiotherapy Improves EFS in Locally Advanced Nasopharyngeal Carcinoma

Sacituzumab Govitecan Displays OS Benefit in Pretreated HR+/HER2– Breast Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact